Radiation Therapy and HL
The use of radiation therapy (RT) has been shown to improve 10-year survival rates in patients with stage I-II Hodgkin’s lymphoma (HL). However, the use of RT in this patient population declined from 56% to 41% between 1998 and 2011.
When asked, physicians indicated that they did not use RT because it was not part of the planned treatment strategy. In this study, 41,502 patients who had been diagnosed with stage I-II HL were selected from the National Cancer Data Base. Among these patients, 96% (n = 39,842) had received chemotherapy and 49% (n =20,441) RT. Ten-year overall survival (OS) for all patients was 80.8%. Among those who received RT, the median OS rate was 84.4% compared with 76.4% who did not receive RT. For more information, click here.